UniProt ID | RL35_HUMAN | |
---|---|---|
UniProt AC | P42766 | |
Protein Name | 60S ribosomal protein L35 | |
Gene Name | RPL35 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 123 | |
Subcellular Localization | ||
Protein Description | Component of the large ribosomal subunit.. | |
Protein Sequence | MAKIKARDLRGKKKEELLKQLDDLKVELSQLRVAKVTGGAASKLSKIRVVRKSIARVLTVINQTQKENLRKFYKGKKYKPLDLRPKKTRAMRRRLNKHEENLKTKKQQRKERLYPLRKYAVKA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Acetylation | ARDLRGKKKEELLKQ HHHCCCHHHHHHHHH | 69.14 | 23749302 | |
13 | Ubiquitination | ARDLRGKKKEELLKQ HHHCCCHHHHHHHHH | 69.14 | 25015289 | |
14 | Ubiquitination | RDLRGKKKEELLKQL HHCCCHHHHHHHHHH | 60.96 | - | |
19 | Ubiquitination | KKKEELLKQLDDLKV HHHHHHHHHHHHHHH | 62.53 | 23000965 | |
19 | Acetylation | KKKEELLKQLDDLKV HHHHHHHHHHHHHHH | 62.53 | 19608861 | |
25 | 2-Hydroxyisobutyrylation | LKQLDDLKVELSQLR HHHHHHHHHHHHHHH | 40.43 | - | |
25 | Ubiquitination | LKQLDDLKVELSQLR HHHHHHHHHHHHHHH | 40.43 | 23000965 | |
25 | Sumoylation | LKQLDDLKVELSQLR HHHHHHHHHHHHHHH | 40.43 | 28112733 | |
25 | Succinylation | LKQLDDLKVELSQLR HHHHHHHHHHHHHHH | 40.43 | 23954790 | |
25 | Acetylation | LKQLDDLKVELSQLR HHHHHHHHHHHHHHH | 40.43 | 26822725 | |
29 | Phosphorylation | DDLKVELSQLRVAKV HHHHHHHHHHHHHHH | 17.42 | 30266825 | |
32 | Methylation | KVELSQLRVAKVTGG HHHHHHHHHHHHHCC | 20.79 | - | |
35 | Ubiquitination | LSQLRVAKVTGGAAS HHHHHHHHHHCCHHH | 37.16 | 23000965 | |
37 | Phosphorylation | QLRVAKVTGGAASKL HHHHHHHHCCHHHHH | 29.23 | 22985185 | |
42 | Phosphorylation | KVTGGAASKLSKIRV HHHCCHHHHHHHHHH | 33.33 | 24670416 | |
43 | Ubiquitination | VTGGAASKLSKIRVV HHCCHHHHHHHHHHH | 52.64 | 23000965 | |
43 | Acetylation | VTGGAASKLSKIRVV HHCCHHHHHHHHHHH | 52.64 | 19608861 | |
43 | 2-Hydroxyisobutyrylation | VTGGAASKLSKIRVV HHCCHHHHHHHHHHH | 52.64 | - | |
45 | Phosphorylation | GGAASKLSKIRVVRK CCHHHHHHHHHHHHH | 29.76 | 25159151 | |
46 | Ubiquitination | GAASKLSKIRVVRKS CHHHHHHHHHHHHHH | 44.99 | 23000965 | |
46 | Acetylation | GAASKLSKIRVVRKS CHHHHHHHHHHHHHH | 44.99 | 19814843 | |
53 | Phosphorylation | KIRVVRKSIARVLTV HHHHHHHHHHHHHHH | 15.77 | 29514088 | |
59 | Phosphorylation | KSIARVLTVINQTQK HHHHHHHHHHHHHHH | 19.24 | 29514088 | |
64 | Phosphorylation | VLTVINQTQKENLRK HHHHHHHHHHHHHHH | 36.80 | 21712546 | |
66 | Ubiquitination | TVINQTQKENLRKFY HHHHHHHHHHHHHHH | 52.54 | 23000965 | |
66 | 2-Hydroxyisobutyrylation | TVINQTQKENLRKFY HHHHHHHHHHHHHHH | 52.54 | - | |
66 | Succinylation | TVINQTQKENLRKFY HHHHHHHHHHHHHHH | 52.54 | 23954790 | |
66 | Acetylation | TVINQTQKENLRKFY HHHHHHHHHHHHHHH | 52.54 | 26051181 | |
71 | Ubiquitination | TQKENLRKFYKGKKY HHHHHHHHHHCCCCC | 57.10 | 23000965 | |
74 | Ubiquitination | ENLRKFYKGKKYKPL HHHHHHHCCCCCCCC | 68.34 | 22817900 | |
76 | Ubiquitination | LRKFYKGKKYKPLDL HHHHHCCCCCCCCCC | 49.10 | 22817900 | |
77 | Ubiquitination | RKFYKGKKYKPLDLR HHHHCCCCCCCCCCC | 68.15 | 29967540 | |
78 | Phosphorylation | KFYKGKKYKPLDLRP HHHCCCCCCCCCCCC | 22.71 | 28152594 | |
79 | Ubiquitination | FYKGKKYKPLDLRPK HHCCCCCCCCCCCCH | 48.24 | 22817900 | |
79 | Acetylation | FYKGKKYKPLDLRPK HHCCCCCCCCCCCCH | 48.24 | 26051181 | |
84 | Methylation | KYKPLDLRPKKTRAM CCCCCCCCCHHHHHH | 40.43 | 115492137 | |
86 | Ubiquitination | KPLDLRPKKTRAMRR CCCCCCCHHHHHHHH | 61.41 | 32015554 | |
86 | 2-Hydroxyisobutyrylation | KPLDLRPKKTRAMRR CCCCCCCHHHHHHHH | 61.41 | - | |
97 | Ubiquitination | AMRRRLNKHEENLKT HHHHHHHHHHHHHHH | 57.92 | 33845483 | |
97 | Acetylation | AMRRRLNKHEENLKT HHHHHHHHHHHHHHH | 57.92 | 25825284 | |
103 | Ubiquitination | NKHEENLKTKKQQRK HHHHHHHHHHHHHHH | 70.63 | 33845483 | |
103 | 2-Hydroxyisobutyrylation | NKHEENLKTKKQQRK HHHHHHHHHHHHHHH | 70.63 | - | |
106 | Ubiquitination | EENLKTKKQQRKERL HHHHHHHHHHHHHHH | 57.82 | 24816145 | |
117 | Methylation | KERLYPLRKYAVKA- HHHHHHHHHHHHCC- | 25.99 | 115492121 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL35_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL35_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL35_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19 AND LYS-43, AND MASSSPECTROMETRY. |